Cardior Pharmaceuticals logo

Cardior Pharmaceuticals

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

2

Funding Rounds

$91.7m

Money raised

Overview

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

Funding

Funding series

Funding Series Analysis

The company Cardior Pharmaceuticals has raised a total of $91.7m in funding over 2 rounds.

Key Insights:

  • Cardior Pharmaceuticals Series B round, August 2021: $75.3m
  • Cardior Pharmaceuticals Series A round, May 2017: $16.4m
Cardior Pharmaceuticals logo
Cardior Pharmaceuticals Series B round, August 2021 $75.3m
Cardior Pharmaceuticals logo
Cardior Pharmaceuticals Series A round, May 2017 $16.4m